Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis

por Camacho-Toledano, Celia, Machín-Díaz, Isabel, Calahorra, Leticia, Cabañas-Cotillas, María, Otaegui, David, Castillo-Triviño, Tamara, Villar, Luisa María, Costa-Frossard, Lucienne, Comabella, Manuel, Midaglia, Luciana, García-Domínguez, José Manuel, García-Arocha, Jennifer, Ortega, María Cristina, Clemente, Diego
Publicado 2022

Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis

por Ortega, María Cristina, Lebrón-Galán, Rafael, Machín-Díaz, Isabel, Naughton, Michelle, Pérez-Molina, Inmaculada, García-Arocha, Jennifer, Garcia-Dominguez, Jose Manuel, Goicoechea-Briceño, Haydee, Vila-del Sol, Virginia, Quintanero-Casero, Víctor, García-Montero, Rosa, Galán, Victoria, Calahorra, Leticia, Camacho-Toledano, Celia, Martínez-Ginés, María Luisa, Fitzgerald, Denise C., Clemente, Diego
Publicado 2023